Tissue | Expression Dynamics | Abbreviation |
Breast | | IDC: Invasive ductal carcinoma |
DCIS: Ductal carcinoma in situ |
Precancer(BRCA1-mut): Precancerous lesion from BRCA1 mutation carriers |
Colorectum (GSE201348) | | FAP: Familial adenomatous polyposis |
CRC: Colorectal cancer |
Colorectum (HTA11) | | AD: Adenomas |
SER: Sessile serrated lesions |
MSI-H: Microsatellite-high colorectal cancer |
MSS: Microsatellite stable colorectal cancer |
Endometrium | | AEH: Atypical endometrial hyperplasia |
EEC: Endometrioid Cancer |
Esophagus | | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
GC | | CAG: Chronic atrophic gastritis |
CAG with IM: Chronic atrophic gastritis with intestinal metaplasia |
CSG: Chronic superficial gastritis |
GC: Gastric cancer |
SIM: Severe intestinal metaplasia |
WIM: Wild intestinal metaplasia |
Liver | | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Lung | | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ |
IAC: Invasive lung adenocarcinoma |
MIA: Minimally invasive adenocarcinoma |
Oral Cavity | | EOLP: Erosive Oral lichen planus |
LP: leukoplakia |
NEOLP: Non-erosive oral lichen planus |
OSCC: Oral squamous cell carcinoma |
Prostate | | BPH: Benign Prostatic Hyperplasia |
Skin | | AK: Actinic keratosis |
cSCC: Cutaneous squamous cell carcinoma |
SCCIS:squamous cell carcinoma in situ |
Thyroid | | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ARGLU1 | SNV | Missense_Mutation | novel | c.520G>A | p.Glu174Lys | p.E174K | Q9NWB6 | protein_coding | tolerated(0.11) | benign(0.122) | TCGA-AX-A3FT-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ARGLU1 | SNV | Missense_Mutation | | c.622N>G | p.Asn208Asp | p.N208D | Q9NWB6 | protein_coding | deleterious(0.01) | probably_damaging(0.953) | TCGA-B5-A11N-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ARGLU1 | SNV | Missense_Mutation | novel | c.737N>A | p.Arg246His | p.R246H | Q9NWB6 | protein_coding | deleterious(0) | possibly_damaging(0.49) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ARGLU1 | SNV | Missense_Mutation | novel | c.629G>A | p.Arg210Gln | p.R210Q | Q9NWB6 | protein_coding | tolerated(0.09) | probably_damaging(0.947) | TCGA-BK-A6W3-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ARGLU1 | SNV | Missense_Mutation | novel | c.476N>A | p.Arg159Gln | p.R159Q | Q9NWB6 | protein_coding | deleterious(0.01) | possibly_damaging(0.644) | TCGA-BS-A0UF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ARGLU1 | SNV | Missense_Mutation | | c.692G>T | p.Arg231Ile | p.R231I | Q9NWB6 | protein_coding | deleterious(0) | probably_damaging(0.975) | TCGA-D1-A17Q-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ARGLU1 | SNV | Missense_Mutation | | c.497N>A | p.Arg166His | p.R166H | Q9NWB6 | protein_coding | tolerated(0.25) | probably_damaging(0.984) | TCGA-D1-A1NY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | SD |
ARGLU1 | SNV | Missense_Mutation | novel | c.128N>A | p.Ser43Tyr | p.S43Y | Q9NWB6 | protein_coding | deleterious(0.03) | probably_damaging(0.983) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
ARGLU1 | SNV | Missense_Mutation | novel | c.629G>A | p.Arg210Gln | p.R210Q | Q9NWB6 | protein_coding | tolerated(0.09) | probably_damaging(0.947) | TCGA-E6-A1M0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
ARGLU1 | SNV | Missense_Mutation | novel | c.50N>A | p.Ser17Asn | p.S17N | Q9NWB6 | protein_coding | tolerated(0.21) | benign(0.011) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |